Literature DB >> 11875574

Characterization of a common precursor population for dendritic cells.

Gloria Martínez del Hoyo1, Pilar Martín, Héctor Hernández Vargas, Sara Ruiz, Cristina Fernández Arias, Carlos Ardavín.   

Abstract

Dendritic cells (DCs) are essential for the establishment of immune responses against pathogens and tumour cells, and thus have great potential as tools for vaccination and cancer immunotherapy trials. Experimental evidence has led to a dual DC differentiation model, which involves the existence of both myeloid- and lymphoid-derived DCs. But this concept has been challenged by recent reports demonstrating that both CD8- and CD8+ DCs, considered in mice as archetypes of myeloid and lymphoid DCs respectively, can be generated from either lymphoid or myeloid progenitors. The issue of DC physiological derivation therefore remains an open question. Here we report the characterization of a DC-committed precursor population, which has the capacity to generate all the DC subpopulations present in mouse lymphoid organs---including CD8- and CD8+ DCs, as well as the B220+ DC subset---but which is devoid of myeloid or lymphoid differentiation potential. These data support an alternative model of DC development, in which there is an independent, common DC differentiation pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11875574     DOI: 10.1038/4151043a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  42 in total

1.  Langerhans cells renew in the skin throughout life under steady-state conditions.

Authors:  Miriam Merad; Markus G Manz; Holger Karsunky; Amy Wagers; Wendy Peters; Israel Charo; Irving L Weissman; Jason G Cyster; Edgar G Engleman
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

2.  Activation of bone marrow-resident memory T cells by circulating, antigen-bearing dendritic cells.

Authors:  Lois L Cavanagh; Roberto Bonasio; Irina B Mazo; Cornelia Halin; Guiying Cheng; Adrianus W M van der Velden; Annaiah Cariappa; Catherine Chase; Paul Russell; Michael N Starnbach; Pandelakis A Koni; Shiv Pillai; Wolfgang Weninger; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2005-09-11       Impact factor: 25.606

Review 3.  Dendritic cells at the oral mucosal interface.

Authors:  C W Cutler; R Jotwani
Journal:  J Dent Res       Date:  2006-08       Impact factor: 6.116

Review 4.  Exploiting dendritic cells for active immunotherapy of cancer and chronic infections.

Authors:  David W O'Neill; Nina Bhardwaj
Journal:  Mol Biotechnol       Date:  2007-06       Impact factor: 2.695

5.  Vaginal epithelial dendritic cells renew from bone marrow precursors.

Authors:  Norifumi Iijima; Melissa M Linehan; Sem Saeland; Akiko Iwasaki
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-15       Impact factor: 11.205

Review 6.  Dendritic cell homeostasis.

Authors:  Miriam Merad; Markus G Manz
Journal:  Blood       Date:  2009-01-27       Impact factor: 22.113

Review 7.  The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria.

Authors:  A J Stagg; A L Hart; S C Knight; M A Kamm
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

8.  B-Cell Depletion Promotes Aortic Infiltration of Immunosuppressive Cells and Is Protective of Experimental Aortic Aneurysm.

Authors:  Basil Schaheen; Emily A Downs; Vlad Serbulea; Camila C P Almenara; Michael Spinosa; Gang Su; Yunge Zhao; Prasad Srikakulapu; Cherié Butts; Coleen A McNamara; Norbert Leitinger; Gilbert R Upchurch; Akshaya K Meher; Gorav Ailawadi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-09-15       Impact factor: 8.311

Review 9.  Migration of dendritic cells.

Authors:  Hiroyuki Yoneyama; Kenjiro Matsuno; Kouji Matsushimaa
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

10.  IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression.

Authors:  Kazu Kikuchi; Hirotake Kasai; Akiko Watanabe; Anne Y Lai; Motonari Kondo
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.